Displaying 1 to 20 of 64 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Aciex Therapeutics Inc Specialty pharmaceutical company focused on the development of therapeutics to treat front of the eye diseases. |
United States | N/A |
||
|
|
Altheos Inc A drug development company focused on next generation intraocular pressure (IOP) lowering agents for glaucoma and ocular hypertension. |
United States | N/A Active |
||
|
|
Amerifit Nutrition Inc Develops, sources, markets, and sells branded nutritional supplement products, targeting select consumer growth segments. |
United States | N/A |
||
|
|
Aquabounty Technologies Inc Develops innovative technologies to significantly improve the economics and productivity of fish farming. |
United States | N/A |
||
|
|
Aviir Inc Assists in the prevention of cardiovascular disease and management of related conditions by delivering innovative cardiometabolic tests and associated |
United States | N/A |
||
|
|
Bioren Inc Antibody discovery and optimization company developing a rational approach to antibody engineering. |
United States | N/A |
||
|
|
BioSeek Inc Improving the success rate of pharmaceutical research and development by integrating human biology from the earliest stages of drug discovery onward. |
United States | N/A |
||
|
|
BrainCells Inc A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases. |
United States | N/A |
||
|
|
Cadence Pharmaceuticals Inc Focused on in-licensing, developing, and commercializing proprietary product candidates principally for use in the hospital setting. |
United States | N/A |
||
|
|
Calypso Medical Technologies Inc A medical device company developing innovative tools and therapies for the oncology marketa advancing cancer radiation treatment. |
United States | 2 Nov 2009 | Series E Round participant. Active |
|
|
|
Calypso Medical Technologies Inc A medical device company developing innovative tools and therapies for the oncology marketa advancing cancer radiation treatment. |
United States | 7 Jan 2005 | Series C Active |
|
|
|
Chemdex Internet clearinghouse to facilitate the distribution of specialty chemicals, biochemicals, and reagents. |
United States | N/A |
||
|
|
Conatus Pharmaceuticals Inc Biotechnology company focused on the development of innovative human therapeutics to treat liver disease and cancer. |
United States | N/A |
||
|
|
Dermira Inc Specialty pharmaceutical company with the goal of establishing a presence in the dermatology space by acquiring marketed products and a pipeline of la |
United States | N/A |
||
|
|
EnteroMedics Inc Develops therapeutic devices for the treatment of obesity. Its VSM technology uses electrical signals, delivered by an implantable electrode array, to |
United States | N/A |
||
|
|
Eos Biotechnology Inc Next generation genomics company that uses the complete human genome to identify new drug targets and develop antibodies against those targets to trea |
United States | N/A |
||
|
|
Epizyme Inc Focusing on the discovery and development of innovative drugs targeting epigenetic enzymes, in particular histone methyltransferases (HMTs). |
United States | N/A |
||
|
|
Epoch Biosciences Inc Biotech company focused on development and commercialization of proprietary nucleic acid chemistries for research and diagnostic applications. |
United States | N/A |
||
|
|
Epocrates Inc Largest mobile computing network for physicians using hand-held PDA device. |
United States | N/A |
||
|
|
GenturaDx-USA Inc Molecular diagnostic company focused on making multiplexed molecular testing both affordable and practical for any laboratory to perform. |
United States | N/A |